scispace - formally typeset
I

Irene Orlow

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  190
Citations -  11167

Irene Orlow is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 45, co-authored 174 publications receiving 10088 citations. Previous affiliations of Irene Orlow include Roswell Park Cancer Institute & Kettering University.

Papers
More filters
Journal ArticleDOI

The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53

TL;DR: It is shown that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2.
Journal ArticleDOI

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Ganna Chornokur, +158 more
- 19 Jun 2015 - 
TL;DR: Associations between inherited cellular transport gene variants and risk of EOC histologic subtypes are revealed on a large cohort of women.
Journal ArticleDOI

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Stig E. Bojesen, +455 more
- 01 Apr 2013 - 
TL;DR: Using the Illumina custom genotyping array iCOGs, SNPs at the TERT locus in breast, ovarian and BRCA1 mutation carrier cancer cases and controls and leukocyte telomere measurements are analyzed to find associations cluster into three independent peaks.
Journal ArticleDOI

Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta

TL;DR: In intact EL4 thymoma cells, IL-1 beta stimulated a rapid decrease of sphingomyelin and an elevation of ceramide, and enhanced ceramide-activated protein kinase activity, demonstrating tight coupling to the receptor.
Journal ArticleDOI

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Paul D.P. Pharoah, +176 more
- 01 Apr 2013 - 
TL;DR: An integrated molecular analysis of genes and regulatory regions at these loci provided evidence for functional mechanisms underlying susceptibility and implicated CHMP4C in the pathogenesis of ovarian cancer.